Benzinga's Top Upgrades, Downgrades For September 14, 2020

Upgrades

• For Amkor Technology Inc AMKR, Credit Suisse upgraded the previous rating of Neutral to the current rating Outperform. For the second quarter, Amkor Technology had an EPS of $0.23, compared to year-ago quarter EPS of $0.01. The current stock performance of Amkor Technology shows a 52-week-high of $15.80 and a 52-week-low of $5.40. Moreover, at the end of the last trading period, the closing price was at $10.88.
• For Andersons Inc ANDE, BMO Capital upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, Andersons showed an EPS of $0.88, compared to $0.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.82 and a 52-week-low of $10.00. Andersons closed at $16.59 at the end of the last trading period.
• According to Barclays, the prior rating for Cirrus Logic Inc CRUS was changed from Underweight to Equal-Weight. Cirrus Logic earned $0.53 in the first quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.63 and a 52-week-low of $47.04. Cirrus Logic closed at $58.06 at the end of the last trading period.
• According to JP Morgan, the prior rating for Genuine Parts Co GPC was changed from Neutral to Overweight. For the second quarter, Genuine Parts had an EPS of $1.32, compared to year-ago quarter EPS of $1.57. The stock has a 52-week-high of $108.58 and a 52-week-low of $49.68. At the end of the last trading period, Genuine Parts closed at $100.66.
• For World Wrestling Entertainment Inc WWE, Loop Capital upgraded the previous rating of Sell to the current rating Hold. World Wrestling Enter earned $0.45 in the second quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $76.44 and a 52-week-low of $29.10. World Wrestling Enter closed at $41.42 at the end of the last trading period.
• For Murphy Oil Corp MUR, MKM Partners upgraded the previous rating of Neutral to the current rating Buy. Murphy Oil earned $0.71 in the second quarter, compared to $0.21 in the year-ago quarter. The stock has a 52-week-high of $28.12 and a 52-week-low of $4.50. At the end of the last trading period, Murphy Oil closed at $10.03.
• According to Guggenheim, the prior rating for Consolidated Edison Inc ED was changed from Sell to Neutral. Consolidated Edison earned $0.60 in the second quarter, compared to $0.58 in the year-ago quarter. At the moment, the stock has a 52-week-high of $95.10 and a 52-week-low of $62.03. Consolidated Edison closed at $72.74 at the end of the last trading period.
• According to Wells Fargo, the prior rating for Cimarex Energy Co XEC was changed from Equal-Weight to Overweight. In the second quarter, Cimarex Energy showed an EPS of $0.51, compared to $0.82 from the year-ago quarter. The stock has a 52-week-high of $55.29 and a 52-week-low of $12.15. At the end of the last trading period, Cimarex Energy closed at $24.25.
• Telsey Advisory Group upgraded the previous rating for GameStop Corp GME from Market Perform to Outperform. In the second quarter, GameStop showed an EPS of $1.40, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $8.45 and a 52-week-low of $2.57. At the end of the last trading period, GameStop closed at $6.09.
• Goldman Sachs upgraded the previous rating for Micron Technology Inc MU from Neutral to Buy. Micron Technology earned $0.82 in the third quarter, compared to $1.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.19 and a 52-week-low of $31.13. Micron Technology closed at $46.09 at the end of the last trading period.
• According to Jefferies, the prior rating for GameStop Corp GME was changed from Hold to Buy. For the second quarter, GameStop had an EPS of $1.40, compared to year-ago quarter EPS of $0.32. The current stock performance of GameStop shows a 52-week-high of $8.45 and a 52-week-low of $2.57. Moreover, at the end of the last trading period, the closing price was at $6.09.
• For Vir Biotechnology Inc VIR, Goldman Sachs upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Vir Biotechnology earned $0.27. At the moment, the stock has a 52-week-high of $75.00 and a 52-week-low of $11.65. Vir Biotechnology closed at $28.38 at the end of the last trading period.

Downgrades

• JP Morgan downgraded the previous rating for Casey's General Stores Inc CASY from Neutral to Underweight. In the first quarter, Casey's General Stores showed an EPS of $3.24, compared to $2.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $183.45 and a 52-week-low of $114.01. Casey's General Stores closed at $179.00 at the end of the last trading period.
• Goldman Sachs downgraded the previous rating for Jazz Pharmaceuticals PLC JAZZ from Neutral to Sell. In the second quarter, Jazz Pharmaceuticals showed an EPS of $3.71, compared to $4.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $154.24 and a 52-week-low of $86.88. Jazz Pharmaceuticals closed at $136.80 at the end of the last trading period.
• According to B of A Securities, the prior rating for The Kroger Co KR was changed from Buy to Neutral. In the second quarter, Kroger showed an EPS of $0.73, compared to $0.44 from the year-ago quarter. The current stock performance of Kroger shows a 52-week-high of $37.22 and a 52-week-low of $23.71. Moreover, at the end of the last trading period, the closing price was at $34.37.
• According to Goldman Sachs, the prior rating for MGM Resorts International MGM was changed from Neutral to Sell. MGM Resorts Intl earned $1.52 in the second quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.63 and a 52-week-low of $5.90. MGM Resorts Intl closed at $22.72 at the end of the last trading period.
• Morgan Stanley downgraded the previous rating for Macerich Co MAC from Equal-Weight to Underweight. In the second quarter, Macerich earned $0.39. The current stock performance of Macerich shows a 52-week-high of $34.13 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at $7.36.
• According to HC Wainwright & Co., the prior rating for Immunomedics Inc IMMU was changed from Buy to Neutral. For the fourth quarter, Immunomedics had an EPS of $0.73, compared to year-ago quarter EPS of $0.40. At the moment, the stock has a 52-week-high of $45.69 and a 52-week-low of $8.80. Immunomedics closed at $42.25 at the end of the last trading period.
• For Kala Pharmaceuticals Inc KALA, Jefferies downgraded the previous rating of Buy to the current rating Hold. In the second quarter, Kala Pharmaceuticals showed an EPS of $0.42, compared to $0.70 from the year-ago quarter. The stock has a 52-week-high of $14.68 and a 52-week-low of $3.24. At the end of the last trading period, Kala Pharmaceuticals closed at $8.77.

Initiations

• With a current rating of Buy, Argus Research initiated coverage on Generac Holdings Inc GNRC. The price target seems to have been set at $210.00 for Generac Hldgs. Generac Hldgs earned $1.40 in the second quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Generac Hldgs shows a 52-week-high of $194.35 and a 52-week-low of $75.10. Moreover, at the end of the last trading period, the closing price was at $178.40.
• With a current rating of Overweight, Morgan Stanley initiated coverage on Avantor Inc AVTR. The price target seems to have been set at $24.00 for Avantor. Avantor earned $0.19 in the second quarter, compared to $0.14 in the year-ago quarter. The stock has a 52-week-high of $22.95 and a 52-week-low of $6.66. At the end of the last trading period, Avantor closed at $21.50.
• Goldman Sachs initiated coverage on Caesars Entertainment Corp CZR with a Neutral rating. The price target for Caesars Entertainment is set to $56.00. Caesars Entertainment earned $1.25 in the second quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $53.21 and a 52-week-low of $3.22. Caesars Entertainment closed at $50.11 at the end of the last trading period.
• With a current rating of Buy, B of A Securities initiated coverage on Chart Industries Inc GTLS. The price target seems to have been set at $86.00 for Chart Industries. Chart Industries earned $0.63 in the second quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Chart Industries shows a 52-week-high of $77.56 and a 52-week-low of $15.00. Moreover, at the end of the last trading period, the closing price was at $67.47.
• With a current rating of Buy, Jefferies initiated coverage on Harmony Biosciences Holdings Inc HRMY. The price target seems to have been set at $51.00 for Harmony Biosciences. Moreover, at the end of the last trading period, the closing price was at $44.14.
• With a current rating of Overweight, Morgan Stanley initiated coverage on Thermo Fisher Scientific Inc TMO. The price target seems to have been set at $485.00 for Thermo Fisher Scientific. Thermo Fisher Scientific earned $3.89 in the second quarter, compared to $3.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $441.96 and a 52-week-low of $250.21. Thermo Fisher Scientific closed at $431.13 at the end of the last trading period.
• With a current rating of Buy, Guggenheim initiated coverage on Trevena Inc TRVN. The price target seems to have been set at $5.00 for Trevena. For the second quarter, Trevena had an EPS of $0.06, compared to year-ago quarter EPS of $0.05. The current stock performance of Trevena shows a 52-week-high of $3.68 and a 52-week-low of $0.46. Moreover, at the end of the last trading period, the closing price was at $1.78.
• With a current rating of Buy, Needham initiated coverage on Overstock.com Inc OSTK. The price target seems to have been set at $96.00 for Overstock.com. Overstock.com earned $0.72 in the second quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $128.50 and a 52-week-low of $2.53. At the end of the last trading period, Overstock.com closed at $65.15.
• With a current rating of Buy, Deutsche Bank initiated coverage on Arconic Corp ARNC. The price target seems to have been set at $32.00 for Arconic. In the second quarter, Arconic showed an EPS of $0.84, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $34.27 and a 52-week-low of $5.80. At the end of the last trading period, Arconic closed at $19.07.